wegovy vs ozempic vs tirzepatide Prices of Mounjaro Wegovy: How much they cost in the US, UK, India and around the world Tirzepatide vs. Ozempic: Comparing Diabetes

I appreciate the unique perspective you bring to every topic you cover

6, 2015, pp

Drugs like Ozempic and Wegovy (glucagon-like peptide-1 agonists (GLP-1s) that contain the active ingredient semaglutide), as well as Mounjaro and Zepbound (GIP/GLP-1 agonists that contain the active ingredient tirzepatide), are injected once a week

Ken Berry

Some aspects of the research appear promising, while others remain unproven: What appears promising so far: Reduced substance-seeking behavior observed in animal models Anecdotal and observational reports of decreased cravings in some individuals Growing scientific interest in shared reward pathways between appetite and addiction What remains unproven or unclear: Whether observed effects lead to sustained recovery outcomes How GLP-1s affect the psychological and social dimensions of addiction Whether benefits, if present, are consistent across substances or populations Differences in study design also limit interpretation: Animal trials do not reliably predict human outcomes Observational data cannot establish causation Controlled human trials remain small, limited, and inconsistent Safety considerations are equally important and must be weighed carefully: Common side effects include nausea, appetite suppression, and gastrointestinal distress Changes in appetite or weight may interact with existing mental health symptoms For individuals with eating disorders, appetite-suppressing effects may pose particular risks Given these uncertainties, GLP-1 medications should not replace evidence-based addiction treatments